Brain Cancer Canada

What Brain Cancer Canada does

Brain Cancer Canada is a national charity founded in 2015 and headquartered in Toronto, Ontario, with a secondary office in Calgary, Alberta. It is the only national charity in Canada exclusively dedicated to funding brain cancer research and neurosurgical technologies for both pediatric and adult primary malignant brain tumours. The organization is 100% volunteer-driven with no paid staff, a structural choice that maximizes the share of donations directed to research. Since 2015 it has directed over $3 million to brain cancer research, supporting 31 projects across more than a dozen Canadian institutions via a Scientific Advisory Committee that evaluates grant proposals. Its mission spans basic, translational, and clinical research, with active funding in glioblastoma, DIPG/DMG-P, medulloblastoma, IDH-mutant gliomas, and neurosurgical technology (e.g., high-resolution ultrasound endoscope development).

The organization is not a technology company; it has no proprietary technology products. Its "platform" is a grantmaking and fundraising operation built on third-party infrastructure: an Akaraisin donation portal, Benevity/CanadaHelps/United Way/Charitable Impact/CAF Canada for workplace giving, and Rafflebox for 50/50 raffles. Core offerings include individual donation processing (one-time, monthly recurring, in-memory, legacy, Fund-a-Grant), annual community events (Gala for Brain Cancer Research with ~700 guests, Golf Tournament with sponsorship tiers up to $25,000, 50/50 raffle), patient and caregiver resource hub, advocacy initiatives (including testimony to Canada Drug Agency/CADTH), and a recurring Brain Cancer Awareness Month campaign in May featuring landmark illuminations across Canada. Revenue derives entirely from charitable giving: individual donations, corporate partnerships and sponsorships (founding sponsor Scotia Wealth Management, largest donor Auto|One Group with $300K+ over four years, Saporito Foods since 2018), legacy gifts, and Fund-a-Grant named research awards.

Name

Brain Cancer Canada

Legal name

Brain Cancer Canada

Website

https://braincancercanada.ca

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Brain Cancer Canada is a 100% volunteer-driven national charity that funds brain cancer research and neurosurgical technologies and advocates for patients, having directed over $3 million to 31 projects across Canadian institutions since 2015.

Ownership category

akta.pro rank

Product category

Cancer Research Charity

NAICS

Grantmaking Foundations (813211), Voluntary Health Organizations (813212)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

akta.pro secondary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

Keywords

• Brain cancer research
• Cancer research funding
• Nonprofit health charity
• Charitable grant program
• Neurosurgical technology

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Operations, Marketing or Sales, Others

Revenue model

1. Donations (Individual): Individual Canadians make one-time or recurring (monthly) donations via the organization's website, by phone, or by mail. Donations are used to fund brain cancer research grants and neurosurgical technology acquisitions.
2. Fundraising Events: The organization hosts annual fundraising events including a Gala for Brain Cancer Research (attended by ~700 guests), a Charity Golf Tournament, 50/50 raffles, and community-based events. These events generate revenue through ticket sales, sponsorship packages, and raffle proceeds.
3. Corporate Partnerships & Sponsorships: Corporate partners make direct financial contributions, employee matching gift contributions, and sponsorship purchases at fundraising events (title sponsorship, dinner sponsorship, hole sponsorship, etc.). Founding sponsor Scotia Wealth Management and major donor Auto|One Group have made six-figure cumulative contributions.
4. Legacy Giving: Donors can pledge legacy gifts through wills, life insurance policies, or securities as part of their estate plan, providing long-term sustained revenue to the organization.
5. Fund-a-Grant: Donors can directly fund a specific research grant, with their contribution applied to a named grant award (e.g., Dwayne Andrews Glioblastoma Research Grant, Emily McIntosh Brain Cancer Research Grant).

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels10 records

Core offering

Brain Cancer Canada is a national charity that funds brain cancer research grants and neurosurgical technologies, and advocates for effective treatment of primary malignant brain tumours (pediatric and adult). It operates as a 100% volunteer-driven organization, channeling donations from individuals, corporations, and events through a Scientific Advisory Committee-reviewed grant program to Canadian researchers. Its offerings also include community fundraising events, patient/caregiver resources, and advocacy for drug access.

Product overview

Brain Cancer Canada is a 100% volunteer-driven national charity that funds brain cancer research and neurosurgical technologies for pediatric and adult primary malignant brain tumours. The organization operates as a unified mission-driven entity rather than a platform-plus-modules architecture. Its core offerings include a fundraising platform (Grey Everyday) for creating personal and company fundraisers, online donation processing, a comprehensive patient and caregiver resource hub, a research grant funding program managed through a Scientific Advisory Committee, advocacy initiatives, community events (Galas, Golf Tournaments), and annual Brain Cancer Awareness Month campaigns. The organization directs donations to accelerate advancements in science, advocate for patient access to drugs and treatments, and transform community power to change patient experiences.

Differentiator

Problem solved

Functional benefit

Brands

• 70KM for $70K: A fundraising campaign partnership with RUNWAY, a Toronto-based running community, involving a 70-kilometre ultramarathon to raise $70,000 for brain cancer research.
• Grey in May
• Douglas MacRae Award of Courage
• Dwayne Andrews Glioblastoma Research Grant
• Emily McIntosh Brain Cancer Research Grant

Products and services

• Research Grant Funding Program

Quantifiable outcome

• Directed over $3 million to brain cancer research since 2015, supporting 31 projects across more than a dozen Canadian institutions
• +2 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

14 partnerships are on record, tiered minor.

• RUNWAY (Toronto-based running community)minorGTM or Marketing Partner · 19 September 2026RUNWAY is a Toronto-based running community partnering with Brain Cancer Canada for the '70KM for $70K' fundraising campaign. Noah Lee will run a 70-kilometre ultramarathon from the University of Toronto to McMaster University on September 19, 2026, to raise $70,000 for brain cancer research. Relay teams will join along the route.
• AYA Brain Cancer Network (Adolescent and Young Adult)minorStrategic or Co-development PartnerHealthcare partner providing patient navigation and support resources for adolescent and young adult brain cancer patients across Canada. Part of Brain Cancer Canada's healthcare partner ecosystem.
• Canadian Organization for Rare Disorders (CORD)minorStrategic or Co-development PartnerHealthcare partner supporting patients with rare disorders, including rare brain tumours. CORD advocates for access to therapies and is part of Brain Cancer Canada's partner ecosystem.
• Canada Drug Agency / CADTHminorStrategic or Co-development PartnerHealthcare partner providing reimbursement reviews and health technology assessments. Brain Cancer Canada has provided patient and caregiver testimony to the Formulary Management Expert Committee during drug reimbursement reviews.
• Canadian Neuro-Oncology Meeting (CNOMeeting)minorStrategic or Co-development PartnerHealthcare partner providing education and professional development for neuro-oncology specialists across Canada. Listed as a healthcare community partner of Brain Cancer Canada.
• NovocureminorStrategic or Co-development PartnerHealthcare partner that developed Tumor Treating Fields therapy for glioblastoma. Novocure's device has received Health Canada approval and a positive reimbursement recommendation. Brain Cancer Canada provides patient education about this treatment option.
• Society for Neuro-Oncology (SNO)minorStrategic or Co-development PartnerInternational professional society for neuro-oncology. Listed as a healthcare community partner supporting the brain cancer research community.
• Servier CanadaminorStrategic or Co-development PartnerPharmaceutical company developing cancer therapies. Listed as a healthcare community partner of Brain Cancer Canada.
• BenevityminorChannel Partner/ Reseller/ DistributorCorporate giving platform used by Brain Cancer Canada to accept workplace payroll donations. Benevity integrates employee engagement with charitable giving, enabling employees to donate through their workplace giving programs.
• CanadaHelpsminorChannel Partner/ Reseller/ DistributorOnline donation platform enabling Canadians to make charitable donations. Brain Cancer Canada receives donations through the CanadaHelps platform as part of its corporate giving ecosystem.
• Charitable ImpactminorChannel Partner/ Reseller/ DistributorOnline giving platform that enables workplace giving and individual donations to Brain Cancer Canada.
• United WayminorChannel Partner/ Reseller/ DistributorWorkplace giving platform through which employees can donate to Brain Cancer Canada via payroll deductions.
• Calgary MarathonminorGTM or Marketing PartnerCommunity partner organizing and participating in fundraising events for Brain Cancer Canada. Part of the community events ecosystem supporting brain cancer awareness and fundraising.
• EchoAgeminorGTM or Marketing PartnerCommunity partner enabling kids' birthday fundraisers where guests contribute to both a gift and Brain Cancer Canada research with a single contribution.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Canadian Cancer Society: Canada's largest cancer charity funding across all cancer types including brain, with national infrastructure, large gala, and Relay For Life fundraising channels. Comparable incumbent that competes for the same Canadian charitable dollar while also serving as a potential research collaboration partner.
• Stand Up To Cancer: US research-funding organization supporting multi-institution translational cancer teams, including brain cancer 'Dream Teams.' Comparable because it operates as a higher-profile incumbent in cancer research grantmaking and runs large-scale fundraising events similar in spirit to the BCC Gala.
• Terry Fox Research Institute / Terry Fox Foundation: Iconic Canadian cancer research charity funding multi-institution research programs, including brain cancer-relevant projects. Comparable as a national cancer-research brand and a benchmark for at-scale grantmaking and event-based fundraising in Canada.

Direct peers

• Brain Tumour Foundation of Canada: Canada's largest brain-tumour charity, funding research and patient support across both malignant and non-malignant brain tumours. Directly comparable because it operates in the same disease space, pursues a similar research-grant-plus-patient-support model, and competes for the same Canadian donor base.
• National Brain Tumor Society: US-based nonprofit dedicated to brain tumour research, advocacy, and policy, with a comparable mission focus on malignant brain tumours and accelerating treatments. A directly comparable peer on disease focus and grantmaking/advocacy model, although it operates in the US.
• Childhood Cancer Canada: National Canadian charity funding pediatric cancer research, including pediatric brain tumours (e.g., DIPG), and providing family support. Comparable because it overlaps on pediatric brain cancer funding and shares the same donor pool of disease-specific, family-driven givers.
• Musella Foundation for Brain Tumor Research: US-based brain-tumor-specific nonprofit funding research and running patient education/clinical-trial navigation. Directly comparable as a focused brain-tumor research funder with advocacy components; differs primarily on geography and scale.
• ALS Society of Canada: Canadian disease-specific health charity that funds ALS research, advocates for patient access, and supports patients/families. Closely comparable operating model to Brain Cancer Canada on being a disease-specific Canadian grantmaker with patient advocacy, although the underlying disease differs.
• Pediatric Brain Tumor Foundation: US charity focused on pediatric brain tumour research and family support, funding translational science and clinical trials. Comparable peer because it overlaps on pediatric brain cancer (e.g., DIPG/DMG) and shares a translational research funding orientation.

Others

• Health Charity Coalition of Canada: Coalition representing Canada's major health charities on policy, funding, and advocacy. Comparable as an ecosystem/adjacent participant for benchmarking operational practice, donor trends, and policy advocacy posture rather than as a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/brain-cancer-canada

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Brain Cancer Canada